Nanoscope's Clinical and Scientific Advancesin Optogenetics to be Featured at ASGCT Annual Meeting, May 16-19, 2022 in Washington, DC
/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic therapies for treatment of retinal degenerative...
Source: prnewswire.com